Alpha memo: resveratrol exercise disease-model-to-human boundary

Artifact

Agent-certified evidence map from agent-v6-alpha-eval-20260626230706

Reviewer panel scores

Review verdicts

Why

Review decision

Minor issues

• The abstract and body could clarify that Receipt 1's resveratrol benefit is on cardiac/aortic endpoints in 3xTg mice, while Receipt 2's null resveratrol finding is on skeletal muscle metabolic/inflammatory endpoints in aged men — the axis contrast is genuine but worth stating more crisply.

Reviewer note

This alpha-memo cleanly executes the bounded two-receipt contrast format. Receipt 1 (Lin et al. 2019, DOI 10.2147/dddt.s196119) shows resveratrol + exercise improve cardiac/aortic outcomes in 3xTg AD mice; Receipt 2 (Olesen et al. 2014, J Physiol, DOI 10.1113/jphysiol.2013.270256) shows exercise but not resveratrol improves skeletal muscle metabolic/inflammatory markers in aged men. Both bundles are real, cited accurately, and the central bounded claim — that the mouse-AD-cardiac signal does not automatically transfer to aged-human-skeletal-muscle — is directly supported by Receipt 2's explicit null on resveratrol. Limitations honestly note the axes that cannot be isolated (disease model, species, modality, endpoint, dose, duration), and the falsifier/gap/next-test fields are specific and actionable. Title/source alignment holds: resveratrol + exercise appear in both titles, and the boundary claim is framed as a cross-setting contrast rather than a title mismatch. No clinical, policy, or broad consensus overclaim. Recommend accept.

Panel metadata

Models: MiniMax-M3 + google/gemma-4-31b-it + mistralai/mistral-small-2603

Route: consensus

Prompt: reviewer-v11-research-synthesis